Ardelyx Reports Second Quarter 2021 Financial Results
- Friday, August 13, 2021, 7:14
- PR Newswire
- Add a comment
FREMONT, Calif. and WALTHAM, Mass., Aug. 13, 2021 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal…
About the Author
admin has written 21729 stories on this site.